Pinned post
Pleased with the recent interest in this exciting project below. Our website is now up and running to help clinicians and/or patient volunteers, find out more about the study or enrol. Do please get in touch.
🔬 Exciting Opportunity! We’re recruiting for a MRC funded, groundbreaking ‘brain pacemaker’ study to tackle alcohol and opioid addiction through a randomized control trial (RCT). This study leverages Deep Brain Stimulation (DBS), akin to a heart pacemaker, to normalize brain rhythms. Previous trials have shown significant efficacy.
We need:
🔹 Alcohol & Opioid use disorder patients
🔹 Minimum 5-year addiction history with repeated relapses
🔹 Motivated to quit but facing frequent relapses
🔹 May be on methadone/buprenorphine with breakthrough use (greater than 1x/week or 5x/month)
Key points:
✔️ DBS is FDA/CE approved for Parkinson’s (since 1997) & OCD (since 2009)
✔️ FDA Breakthrough Device approval for addiction (2022)
✔️ Safe with over 250,000 devices in use globally
The device targets the nucleus accumbens and ventral internal capsule fibers, similar to successful OCD treatments. Previous RCTs in this area show good results, with some patients achieving prolonged abstinence after years of struggle.
Study design includes physiological mechanism analysis and a clinical RCT, with all participants receiving stimulation in an open-label arm, followed by a crossover trial at six months.
Interested? Join us in pioneering this innovative treatment! 🌟 #AddictionResearch #DBS #ClinicalTrials #BrainPacemaker @valvoon
For more info please see the website: brain-pacer.com
@AlcoholChangeUK @changegrowlive @WeAreWithYou @WeAreWithYou @DDNMagazine @UK_AHA @ActionAddiction @TurningPointUK2 @AlcoholFocus @InstAlcStud
🔬 Exciting Opportunity! We’re recruiting for a MRC funded, groundbreaking ‘brain pacemaker’ study to tackle alcohol and opioid addiction through a randomized control trial (RCT). This study leverages Deep Brain Stimulation (DBS), akin to a heart pacemaker, to normalize brain rhythms. Previous trials have shown significant efficacy.
We need:
🔹 Alcohol & Opioid use disorder patients
🔹 Minimum 5-year addiction history with repeated relapses
🔹 Motivated to quit but facing frequent relapses
🔹 May be on methadone/buprenorphine with breakthrough use (greater than 1x/week or 5x/month)
Key points:
✔️ DBS is FDA/CE approved for Parkinson’s (since 1997) & OCD (since 2009)
✔️ FDA Breakthrough Device approval for addiction (2022)
✔️ Safe with over 250,000 devices in use globally
The device targets the nucleus accumbens and ventral internal capsule fibers, similar to successful OCD treatments. Previous RCTs in this area show good results, with some patients achieving prolonged abstinence after years of struggle.
Study design includes physiological mechanism analysis and a clinical RCT, with all participants receiving stimulation in an open-label arm, followed by a crossover trial at six months.
Interested? Join us in pioneering this innovative treatment! 🌟 #AddictionResearch #DBS #ClinicalTrials #BrainPacemaker @valvoon
For more info please see the website: brain-pacer.com
@AlcoholChangeUK @changegrowlive @WeAreWithYou @WeAreWithYou @DDNMagazine @UK_AHA @ActionAddiction @TurningPointUK2 @AlcoholFocus @InstAlcStud
brain-pacer.com Brain-PACER A new treatment study for addictions 
